Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated
Description
Cases of thromboembolic events in 2021 flared up the discussion about the safety of Astra Zeneca's AZD1222 vaccine. We hereby report three cases of pulmonary embolism (PE), one case of extended portal vein thrombosis, and one case of combined portal
